Keywords
LovastatinHMG-CoA reductaseReductaseCholesterolCoronary heart diseasePharmacologyMedicineEnzymeLimitingChemistryInternal medicineBiochemistry
Affiliated Institutions
Related Publications
Comparison of Once-Daily, niacin Extended-Release/lovastatin with standard doses of atorvastatin and simvastatin (the advicor versus other Cholesterol-Modulating agents trial evaluation [ADVOCATE])
This study compared the relative efficacy of a once-daily niacin extended-release (ER)/lovastatin fixed-dose combination with standard doses of atorvastatin or simvastatin, with...
Once‐daily pravastatin in patients with primary hypercholesterolemia: A dose‐response study
Abstract This multicenter, double‐blind, placebo‐controlled study was conducted to evaluate dose‐response effects and safety of once‐daily administration of pravastatin, a new i...
Publication Info
- Year
- 2003
- Type
- review
- Volume
- 2
- Issue
- 7
- Pages
- 517-526
- Citations
- 862
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
862
OpenAlex
Cite This
Jonathan A. Tobert
(2003).
Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.
Nature Reviews Drug Discovery
, 2
(7)
, 517-526.
https://doi.org/10.1038/nrd1112
Identifiers
- DOI
- 10.1038/nrd1112